These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 21913056

  • 21. The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors.
    Sturgill TW, Stoddard PB, Cohn SM, Mayo MW.
    Mol Cancer; 2010 May 11; 9():104. PubMed ID: 20459822
    [Abstract] [Full Text] [Related]

  • 22. TCF7L2 genetic defect and type 2 diabetes.
    Cauchi S, Froguel P.
    Curr Diab Rep; 2008 Apr 11; 8(2):149-55. PubMed ID: 18445358
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. TCF/LEFs and Wnt signaling in the nucleus.
    Cadigan KM, Waterman ML.
    Cold Spring Harb Perspect Biol; 2012 Nov 01; 4(11):. PubMed ID: 23024173
    [Abstract] [Full Text] [Related]

  • 29. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, β-catenin, and SMAR1 to repress HIV transcription.
    Henderson LJ, Narasipura SD, Adarichev V, Kashanchi F, Al-Harthi L.
    J Virol; 2012 Sep 01; 86(17):9495-503. PubMed ID: 22674979
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Native promoter reporters validate transcriptional targets.
    Schmalhofer O, Spaderna S, Brabletz T.
    Methods Mol Biol; 2008 Sep 01; 468():111-28. PubMed ID: 19099250
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
    Huang BL, Brugger SM, Lyons KM.
    J Biol Chem; 2010 Sep 03; 285(36):27702-12. PubMed ID: 20571031
    [Abstract] [Full Text] [Related]

  • 34. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
    Hansson O, Zhou Y, Renström E, Osmark P.
    Curr Diab Rep; 2010 Dec 03; 10(6):444-51. PubMed ID: 20878273
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T, Ninomiya-Tsuji J, Matsumoto K.
    Mol Cell Biol; 2003 Feb 03; 23(4):1379-89. PubMed ID: 12556497
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro modulation of TCF7L2 gene expression in human pancreatic cells.
    Khalooghi K, Hashemi S, Mehraban N, Amiri P, Bazzaz JT, Larijani B, Amoli MM.
    Mol Biol Rep; 2009 Nov 03; 36(8):2329-32. PubMed ID: 19156536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.